论文部分内容阅读
盐酸罗匹尼罗(ropinirole hydrochloride,1),化学名4-[2-(二正丙胺基)-乙基]-1,3-二氢-2H-吲哚-2-酮盐酸盐,是英国Smith Kline-Beecham公司开发的自发性帕金森症(简称PD)治疗药物。1996年9月首次在英国上市,商品名Requi~?。本品是一种强效选择性非麦角碱类多巴胺D_2受体激动剂,1998年被FDA批准用于帕金森病以及作为
Ropinirole hydrochloride (1), chemical name 4- [2- (di-n-propylamino) -ethyl] -1,3-dihydro-2H-indol-2- Spontaneous Parkinson’s disease (PD) treatment developed by the Smith Kline-Beecham Company in the United Kingdom. 1996 September for the first time in the UK market, trade name Requi ~ ?. This product is a potent and selective non-ergot class dopamine D 2 receptor agonist approved by the FDA in 1998 for Parkinson’s disease and as